Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.000
-0.040 (-3.85%)
Nov 22, 2024, 4:00 PM EST - Market closed
Indaptus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 10 | 15 | 12 | 47 | - | - |
| Market Cap Growth | -45.37% | 21.38% | -73.92% | - | - | - |
| Enterprise Value | 3 | -1 | -16 | 5 | - | - |
| Last Close Price | 1.00 | 1.76 | 1.45 | 5.70 | - | - |
| PB Ratio | 1.70 | 1.22 | 0.49 | 1.30 | - | - |
| P/TBV Ratio | 2.11 | 1.22 | 0.49 | 1.30 | - | - |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.00 | 0.00 | - | - |
| Quick Ratio | 3.31 | 4.82 | 7.70 | 8.50 | 0.81 | 5.17 |
| Current Ratio | 3.42 | 5.05 | 7.94 | 8.77 | 0.86 | 5.30 |
| Return on Equity (ROE) | -139.60% | -84.04% | -47.32% | -43.25% | -241.13% | - |
| Return on Assets (ROA) | -73.82% | -47.63% | -27.15% | -22.81% | -78.62% | - |
| Return on Capital (ROIC) | -88.80% | -55.39% | -30.67% | -26.96% | -151.34% | - |
| Earnings Yield | -146.06% | -104.31% | -117.58% | -16.51% | - | - |
| FCF Yield | -113.07% | -90.66% | -107.36% | -24.18% | - | - |
| Buyback Yield / Dilution | -4.25% | -1.68% | -101.98% | -110.35% | -165.44% | - |
| Total Shareholder Return | -4.25% | -1.68% | -101.98% | -110.35% | -165.44% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.